In India, where one-in-six people are undernourished, an unlikely business is booming: obesity surgery.
Exposure to air pollution raises the risk of resistance to insulin, a typical warning sign of diabetes, according to a study of almost 400 German children.
Just one soft drink consumed daily can raise the risk of diabetes by 22 percent, a study showed.
GlaxoSmithKline Plc, the U.K.’s largest drugmaker, said first-quarter profit fell 6 percent after losing revenue from several products it divested.
Johnson & Johnson, the world’s largest seller of health-care products, won approval for the first in a new family of diabetes drugs, giving them the edge against rivals developing similar medicines.
Novo Nordisk A/S, the Danish maker of the Victoza diabetes treatment, said the medicine was successful in helping patients lose weight when used to fight obesity in a late-stage clinical trial.
People taking diabetes drugs such as Merck & Co.’s Januvia were affected by pancreatic cell growth and damage that may turn cancerous, a small study found.
Boston Mayor Thomas Menino’s decision to end his reign, the longest in the city’s 383-year history, set off a frenzied contest to replace him in the first mayoral election to lack an incumbent in three decades.
Vitamin D may help prevent those at risk for diabetes from developing the disease, giving doctors and patients a potential tool against the condition, researchers said.
Poxel SA has raised 13 million euros ($17.1 million) in venture backing, which it plans to use to start a mid-stage clinical trial for its experimental Type 2 diabetes drug.